Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Return on Sales (2019 - 2025)

Historic Return on Sales for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to 0.05%.

  • Volitionrx's Return on Sales rose 500.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.68%, marking a year-over-year increase of 56000.0%. This contributed to the annual value of 21.9% for FY2024, which is 244000.0% up from last year.
  • Latest data reveals that Volitionrx reported Return on Sales of 0.05% as of Q3 2025, which was up 500.0% from 0.07% recorded in Q2 2025.
  • Volitionrx's 5-year Return on Sales high stood at 5.13% for Q4 2021, and its period low was 59.99% during Q1 2023.
  • Its 5-year average for Return on Sales is 14.66%, with a median of 0.07% in 2025.
  • As far as peak fluctuations go, Volitionrx's Return on Sales skyrocketed by 106615900bps in 2021, and later plummeted by -607300bps in 2023.
  • Volitionrx's Return on Sales (Quarter) stood at 5.13% in 2021, then plummeted by -85bps to 0.79% in 2022, then plummeted by -4654bps to 35.79% in 2023, then rose by 16bps to 30.16% in 2024, then surged by 100bps to 0.05% in 2025.
  • Its Return on Sales was 0.05% in Q3 2025, compared to 0.07% in Q2 2025 and 22.41% in Q1 2025.